Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 1 hour agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 28 minutes agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 1 day agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via Yahoo News· 10 hours agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 4 hours agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoMethylmalonic acidemia is a rare, genetic disease that prevents the body from breaking down proteins...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 2 days agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...